# Tranexamic Acid for Alloplastic Breast Reconstruction

> **NCT04918589** · PHASE3 · UNKNOWN · sponsor: **McMaster University** · enrollment: 106 (estimated)

## Conditions studied

- Hematoma Postoperative
- Breast Cancer
- Tranexamic Acid

## Interventions

- **DRUG:** Tranexamic acid
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT04918589
- **Lead sponsor:** McMaster University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08
- **Primary completion:** 2024-08
- **Final completion:** 2024-08
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2022-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04918589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04918589, "Tranexamic Acid for Alloplastic Breast Reconstruction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04918589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*